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Background
The Drug Addiction Treatment Act of 2000 created an
opportunity for primary care physicians and addiction
treatment agencies to integrate, as primary care physi-
cians became able to prescribe opiate treatment medica-
tions from their practices. Fourteen years later, a
National Institute on Drug Abuse evidence-based prac-
tice implementation trial in Ohio is finding that physi-
cian capacity is becoming a primary barrier to use of
buprenorphine. This presentation will document: a) the
degree of the physician capacity barrier for specialty
addiction treatment providers wanting to expand their
buprenorphine programs; b) strategies being considered
to overcome this barrier, including telemedicine; and c)
what workflow challenges implementation of telemedi-
cine can expect (based on the experience of a Veterans
Administration [VA] telemedicine study and qualitative
analysis of telemedicine implementation in several
facilities).
Methods
The mixed-methods approach documents physician
capacity limitations and to what degree telemedicine is
being considered to remedy physician capacity short-
falls. Data collection includes written surveys from 47
treatment centers; qualitative interviews with 39 treat-
ment centers; and patient simulations of VA telemedi-
cine programs. For the data analysis, summary statistics
are provided, including characteristics of organizational
participants and buprenorphine prescribing patterns.
The qualitative inductive analysis is designed to identify
contextual and process factors that affect telemedicine
implementation.
Results
Fifty percent (sample = 42) of Ohio treatment providers
report lack of access to buprenorphine-prescribing physi-
cians as a barrier to implementation and expanded use of
buprenorphine. Thirty-eight percent of those identifying
this barrier consider telemedicine as an option to access
physician prescribers. Barriers to telemedicine implemen-
tation are technology incompatibility; inability for tele-
medicine sites and specialty treatment providers to agree
on dosing protocols (including diversion prevention
expectations); and workflow interruptions that occur due
to patient and clinical information not being effectively
transferred between telemedicine sites and community
treatment providers. Organizational strategies to over-
come lack of physician capacity and telemedicine imple-
mentation challenges are discussed.
Conclusion and implications
The lack of physician-prescribing capacity for buprenor-
phine is preventing this evidence-based practice from
achieving higher penetration rates among specialty treat-
ment providers. Telemedicine provides one solution to
re-allocate the distribution of this scarce resource. How-
ever, there will also be challenges in implementing teleme-
dicine that need to be understood, and evidence-based
strategies need to be developed to overcome these chal-
lenges. Successful use of telemedicine may ultimately lead
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